Bovine Lactoferrin Suppresses Tumor Angiogenesis through NF-κB Pathway Inhibition by Binding to TRAF6

• Egile Nagusiak: Nurina Febriyanti Ayuningtyas (Egilea), Chanbora Chea (Egilea), Toshinori Ando (Egilea), Karina Erda Saninggar (Egilea), Keiji Tanimoto (Egilea), Toshihiro Inubushi (Egilea), Nako Maishi (Egilea), Kyoko Hida (Egilea), Masanobu Shindoh (Egilea), Mutsumi Miyauchi (Egilea), Takashi Takata (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Tumor angiogenesis is essential for tumor progression. The inhibition of tumor angiogenesis is a promising therapy for tumors. Bovine lactoferrin (bLF) has been reported as an anti-tumor agent. However, bLF effects on tumor angiogenesis are not well demonstrated. This study evaluated the inhibitory...